Skip to main content

Table 1 Characteristics of patients with uncoated and iodine-coated implants

From: Risk factors for surgical site infection after malignant bone tumor resection and reconstruction

Characteristic

 

Uncoated implant

(n = 236)

Iodine-coated implant

(n = 66)

P value

Age (years)

46 (range, 8–92)

32 (range, 6–85)

<  0.001

Male/Female

135/101

38/28

1.000

Diagnosis

Metastatic tumor

109

10

 
 

Osteosarcoma

76

43

Chondrosarcoma

21

5

MFH/UPS

16

3

Ewing’s sarcoma

6

1

Extraskeletal myxoid chondrosarcoma

1

0

 

Fibrosarcoma

2

1

 

Hemangiopericytoma

1

0

Malignant GCT

1

0

Adamantinoma

2

3

EWSR1 rearranged sarcoma

1

0

Instruments

IM nail

64

0

 

Plate

44

35

Joint prosthesis

47

8

Endoprosthesis

53

20

Screw

6

0

Joint prosthesis and IM nail

1

0

Plate and IM nail

1

1

Joint prosthesis and plate

1

1

External fixation

19

1

Reconstruction

Frozen autograft

91

38

 

Bone graft

10

2

Artificial bone and frozen autograft

0

1

Allograft

5

1

Bone cement

53

1

Bone graft and frozen autograft

3

0

Allograft and frozen autograft

3

0

Autoclaved bone

1

0

Chemotherapy

 

152

53

0.017

Operative time (minutes)

295

327

0.152

  1. MFH = malignant fibrous histiocytoma; UPS = undifferentiated pleomorphic sarcoma; GCT = giant cell tumor; IM = intramedullary